Interestingly, THOR hypermethylation is more common in cancers known to have a low frequency of hTERTp (prostate, lung, colon, and breast cancer), indicating THOR hypermethylation as an alternative hTERT activation mechanism for these tumor types. The gene discussed is THORLNC; the disease is breast cancer.